Sigyn Therapeutics appoints Michael Ryan to board effective Jan 11, 2025

Sigyn Therapeutics, Inc.

Michael Ryan appointed to board; will serve until next stockholder meeting or successor elected.
Ryan is a founder director of Irrus Investments, largest angel syndicate in Ireland, with €40M+ invested in 35 life science and tech firms.
Compensation: $30,000 annual cash retainer plus $50,000 in restricted stock units or options, vesting quarterly over one year.
Previously CEO of Sedana Medical (Nasdaq First North) and Artema Medical (acquired by Datascope).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Ryan

Director

SIGY · Sigyn Therapeutics, Inc.

Effective: 2025-01-11
Filed: January 16, 2025, 6:59 PM ET

On January 11, 2025, our Board of Directors appointed Michael Ryan to our Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Ryan was appointed as Director at Sigyn Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

On January 11, 2025, our Board of Directors appointed Michael Ryan to our Board of Directors.

View on SEC.gov

Sigyn Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-002575

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.